Division of Bacterial, Parasitic and Allergenic Products Jay E. Slater, MD Director, DBPAP.

Slides:

Advertisements

Similar presentations

Host Defenses, Microbial Evasion & Virulence Factors

Advertisements

SC Standard Compare the body shapes of bacteria * Spiral * Coccus * Bacillus.

Laboratory of Immunobiochemistry Site Visit

Host-Pathogen Interactions. Symbiosis Commensual Mutualistic Parasitic.

Overview of Laboratory of Bacterial Polysaccharides By Willie F. Vann, Chief LBP.

Laboratory of Respiratory and Special Pathogens. History of the Laboratories Laboratory of Pertussis Laboratory of Respiratory and Special Pathogens Laboratory.

 Mucous membranes –Conjunctiva –Respiratory –Gastrointestinal tract –Urogenital  Skin –Abrasions or bite  Parenteral –Puncture or injection Portals.

For Lecture 3 Exam The whole test is matching. Be able to match the following with their description: Virulence factors/enzymes The three hemolysis patterns.

Mechanisms of Pathogenicity Microbiology 2314 Definitions Pathogenicity The ability of a pathogen to produce a disease by overcoming the defenses of.

Division of Bacterial, Parasitic and Allergenic Products Jay E. Slater, MD Director, DBPAP 25 October 2013.

Overview of the Division of Viral Products

An Overview of Mission-related Research Office of Blood Research and Review C.D. Atreya, Ph.D. Associate Director for Research OBRR, CBER BPAC, Dec

Deaths and death rates for the 10 leading causes of death in specified age groups: USA, 1999 ( Rates per 100,000) All causes2,391, Diseases of.

Overview of Laboratory of Bacterial Polysaccharides Willie F. Vann, Ph.D. Chief, Laboratory of Bacterial Polysaccharides.

Bacterial vaccines Prepared by: Doaa abu shammala.

Division of Bacterial, Parasitic and Allergenic Products OVRR/CBER/FDA.

Mucosal Vaccines: Prevention of Caries and Periodontal Diseases.

Center for Biologics Evaluation and Research, FDA Site Visit Introduction Michael J. Brennan, Ph.D. for Kathryn M. Carbone, M.D. Associate Director for.

Bacterial Toxins Chapter 14 Add-on.

Division of Bacterial, Parasitic and Allergenic Products Jay E. Slater, MD Director, DBPAP 28 February 2012.

Infection and Disease II Pathogenicity and Infection.

Sequencing capacitiesacademic company based microarray facilitiesacademic company based bioinformaticsacademic proteomic facilitiesacedemic Genome Research.

Research Microorganisms Today you are conducting research to learn the basic characteristics of different microorganisms. This research is particularly.

Division of Bacterial, Parasitic and Allergenic Products Jay E. Slater, MD Director, DBPAP.

Person-to-Person Microbial Diseases Airborne Transmission Respiratory Infections Human Reservoir “Tough Microbes” 10, ,000 bacteria per sneeze.

Overview of the Laboratory of Respiratory and Special Pathogens Michael Schmitt, Ph.D. Chief, Laboratory of Respiratory and Special Pathogens.

Establishment of Infection In order to cause disease pathogen must follow a series of steps –Gain entrance to host –Adherence –Colonization –Avoid Host.

Mechanism of Bacterial Pathogenesis 미생물학교실 권 형 주.

Immunoprevention. Definition By using immunological agents to construct, improve or inhibit immune response, people can prevent some diseases.

1 GRAM POSITIVE & GRAM NEGATIVE BACTERIA Dr. Fawzia Al-O tabi.

Commercial Production of Antibiotics

Musketeers Course October The Mucosal Immune System The organization of the mucosal immune systemThe organization of the mucosal immune system The.

Laboratory of Enteric and Sexually Transmitted Diseases Historical Perspective Origin: Began in Established to review the rapidly increasing.

Division of Bacterial, Parasitic and Allergenic Products OVRR/CBER/FDA.

Medical biology, microbiology, virology, immunology department by As.Prof. O.V. Pokryshko Microbial Mechanisms of Pathogenicity.

Small Talk Cell-to-Cell Communication in Bacteria.

Laboratory of Mycobacterial Diseases and Cellular Immunology Center for Biologics Evaluation and Research.

Chapter 15 Microbial Mechanism of Pathogenicity. Pathogens have to enter the system to cause disease Regions/areas of the body used by microbes to enter.

Division of Bacterial, Parasitic and Allergenic Products OVRR/CBER/FDA.

A study of Epidemiology

Pathogenesis of bacterial Infections

Prof.Hanan Habib Department of Pathology & laboratory medicine, Microbiology Unit, KSU Host-Parasite Relationship )

Chapter 26 Infectious Diseases.

Batterjee Medical College. Dr. Manal El Said Department Head of Microbiology Antimicrobial Drugs: Mechanism of Action.

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.

Division of Bacterial, Parasitic and Allergenic Products OVRR/CBER/FDA.

Laboratory of Immunobiochemistry Ronald L. Rabin, MD Allergenic Products Advisory Committee 12 May 2011.

Laboratory of Methods Development and Quality Control Laboratory Overview September 22, 2005.

Infection and disease Lecture 3 Bacterial toxins Portals of exit Common bacterial diseases.

Laboratory of Immunobiochemistry Ronald L. Rabin, MD Allergenic Products Advisory Committee 18 March 2009.

OFFICE OF VACCINES RESEARCH AND REVIEW Center for Biologics Evaluation and Research Michael J. Brennan, Ph.D. Associate Director for Research OVRR Site.

Office of Vaccines Research and Review

Antimicrobial vaccines List the main types of immunization List the main types of vaccines Describe the advantages and disadvantages of different types.

Overview Laboratory of Bacterial Polysaccharides From cover - Science, 23 March, 2001.

Host Parasite Relationship

OFFICE OF VACCINES RESEARCH AND REVIEW Center for Biologics Evaluation and Research Michael J. Brennan, Ph.D. Associate Director for Research OVRR Site.

Mechanisms of Pathogenicity  Pathogenicity: the ability to cause disease  Virulence: the extent of pathogenicity.

Bacterial Pathogenesis İ. Çağatay Acuner M.D., Clinical Microbiologist, Associate Professor Department of Microbiology Faculty of Medicine, Yeditepe University,

Part II: Reproduction and pathogenic bacteria. Review: Structure of bacteria:

Microbial toxin There are several virulence factors which help to establish disease The virulence of some bacteria is thought to be aided by the production.

Bergey's Phylogenetic In 1923 David Bergey published Bergey's Manual of Determinative It arranged bacteria in 10 orders.

CLASSIFICATION OF MEDICALLY IMPORTANT BACTERIA I. Rigid, thick–walled cell II. Flexible, thin-walled cells, III. Wall-less cells,

Prof. Ramesh Wigneshweraraj

Helpful and Harmful Bacteria

INTRODUCTION TO MEDICAL MICROBIOLOGY & IMMUNOLOGY

Pathogenicity and virulence

Host Parasite Relationship

Bacteria Research.

Presentation transcript:

Division of Bacterial, Parasitic and Allergenic Products Jay E. Slater, MD Director, DBPAP

2/14 Division of Bacterial, Parasitic and Allergenic Products (DBPAP) Merger (1999) of Division of Bacterial Products (DBP) and Division of Allergenic Products and Parasitology (DAPP) Leadership Drusilla Burns, PhD (Acting) Richard Walker, PhD Milan Blake, PhD

3/14 Division of Bacterial, Parasitic and Allergenic Products (DBPAP) Immediate Office of the Director Jay Slater, MD – Director Drusilla Burns, PhD _Deputy Director (Acting) Regulatory Staff Jennifer Bridgewater – Assoc. Dir. Regulatory Policy Tina Roecklein - Regulatory Coordinator 5 FTE Laboratory of Respiratory and Special Pathogens Drusilla Burns, PhD - Chief Juan Arciniega, D Sci James Keller, PhD Tod Merkel, PhD Michael Schmitt, PhD 16 FTE, 7 ORISE Laboratory of Bacterial Polysaccharides Willie Vann, PhD – Chief Mustafa Akkoyunlu, PhD Margaret Bash, MD Wei Wang, PhD John Cipollo, PhD Daron Freedberg, PhD 16 FTE, 11 ORISE Laboratory of Enteric and Sexually Transmitted Diseases Scott Stibitz, Ph.D. – Chief (Acting) Dennis Kopecko, PhD 7 FTE, 13 ORISE Laboratory of Mycobacterial Diseases & Cellular Immunology Sheldon Morris, Ph.D. – Chief Siobhan Cowley, PhD Karen Elkins, PhD 10 FTE, 9 ORISE As of 15 September 2010 Laboratory of Immunobiochemisty Ron Rabin, M.D. – Chief 9 FTE, 7 ORISE

4/14 DBPAP regulatory/research portfolio Non-invasive, toxin producers Bacillus anthracis (Bordetella parapertussis) Bordetella pertussis (Clostridium botulinum) Clostridium tetani Corynebacterium diphtheriae Invasive, protective responses to polysaccharides Haemophilus influenzae Neisseria meningitidis Streptococcus pneumoniae Intracellular (Francisella tularensis) Mycobacterium tuberculosis Mycobacterium bovis Enteric (Campylobacter jejuni) Salmonella typhi (Salmonella typhimurium) (Shigella dysenteriae) Parasite (Plasmodium spp) Other/emerging (Yersinia pestis) (Staphylococcus aureus) Allergenic products (Probiotics)

5/14 DBPAP regulatory/research portfolio Bacterial Polysaccharides (LBP) Non-invasive, toxin producers Bacillus anthracis (Bordetella parapertussis) Bordetella pertussis (Clostridium botulinum) Clostridium tetani Corynebacterium diphtheriae Invasive, protective responses to polysaccharides Haemophilus influenzae Neisseria meningitidis Streptococcus pneumoniae Intracellular (Francisella tularensis) Mycobacterium tuberculosis Mycobacterium bovis Enteric (Campylobacter jejuni) Salmonella typhi (Salmonella typhimurium) (Shigella dysenteriae) Parasite (Plasmodium spp) Other/emerging (Yersinia pestis) (Staphylococcus aureus) Allergenic products (Probiotics)

6/14 DBPAP regulatory/research portfolio Enteric and Sexually Transmitted Diseases (LESTD) Non-invasive, toxin producers Bacillus anthracis (Bordetella parapertussis) Bordetella pertussis (Clostridium botulinum) Clostridium tetani Corynebacterium diphtheriae Invasive, protective responses to polysaccharides Haemophilus influenzae Neisseria meningitidis Streptococcus pneumoniae Intracellular (Francisella tularensis) Mycobacterium tuberculosis Mycobacterium bovis Enteric (Campylobacter jejuni) Salmonella typhi (Salmonella typhimurium) (Shigella dysenteriae) Parasite (Plasmodium spp) Other/emerging (Yersinia pestis) (Staphylococcus aureus) Allergenic products (Probiotics)

7/14 Enteric and Sexually Transmitted Diseases (LESTD) Stibitz Molecular genetics of virulence and virulence-gene regulation in bacterial respiratory pathogens Kopecko Evaluate safety and utility of Salmonella typhi Ty21a as an oral vaccine delivery platform for expression of foreign antigens and delivery of anti-cancer therapies Analyze pathogenesis of and immune responses to Campylobacter jejuni infection in humans Evaluate the vaccine potential of inactivated enteric bacteria

8/14 DBPAP regulatory/research portfolio Immunobiochemistry (LIB) Non-invasive, toxin producers Bacillus anthracis (Bordetella parapertussis) Bordetella pertussis (Clostridium botulinum) Clostridium tetani Corynebacterium diphtheriae Invasive, protective responses to polysaccharides Haemophilus influenzae Neisseria meningitidis Streptococcus pneumoniae Intracellular (Francisella tularensis) Mycobacterium tuberculosis Mycobacterium bovis Enteric (Campylobacter jejuni) Salmonella typhi (Salmonella typhimurium) (Shigella dysenteriae) Parasite (Plasmodium spp) Other/emerging (Yersinia pestis) (Staphylococcus aureus) Allergenic products (Probiotics)

9/14 Immunobiochemistry (LIB) Rabin IFN-  isoforms that mediate immunosuppression induced by the respiratory syncytial virus Slater Development and validation of a multiplex allergen extract potency assay Endotoxins in allergen extracts

10/14 DBPAP regulatory/research portfolio Mycobacterial Diseases and Cellular Immunology (LMDCI) Non-invasive, toxin producers Bacillus anthracis (Bordetella parapertussis) Bordetella pertussis (Clostridium botulinum) Clostridium tetani Corynebacterium diphtheriae Invasive, protective responses to polysaccharides Haemophilus influenzae Neisseria meningitidis Streptococcus pneumoniae Intracellular (Francisella tularensis) Mycobacterium tuberculosis Mycobacterium bovis Enteric (Campylobacter jejuni) Salmonella typhi (Salmonella typhimurium) (Shigella dysenteriae) Parasite (Plasmodium spp) Other/emerging (Yersinia pestis) (Staphylococcus aureus) Allergenic products (Probiotics)

11/14 Mycobacterial Diseases and Cellular Immunology (LMDCI) Elkins Understand innate immune responses to intracellular bacteria in general and LVS in particular, particularly facets with implications for safety and efficacy outcomes. Define mechanisms by which vaccine-induced immune T cells provide protection against intracellular bacteria, and thus establish practical immune correlates Morris Characterization of novel vaccines and immunization strategies against TB Development of assays to facilitate the assessment of TB vaccines Cowley Characterization of unique aspects of mucosal immune responses to intracellular pathogens. Malaria program – collaboration with OBRR

12/14 DBPAP regulatory/research portfolio Respiratory and Special Pathogens (LRSP) Non-invasive, toxin producers Bacillus anthracis (Bordetella parapertussis) Bordetella pertussis (Clostridium botulinum) Clostridium tetani Corynebacterium diphtheriae Invasive, protective responses to polysaccharides Haemophilus influenzae Neisseria meningitidis Streptococcus pneumoniae Intracellular (Francisella tularensis) Mycobacterium tuberculosis Mycobacterium bovis Enteric (Campylobacter jejuni) Salmonella typhi (Salmonella typhimurium) (Shigella dysenteriae) Parasite (Plasmodium spp) Other/emerging (Yersinia pestis) (Staphylococcus aureus) Allergenic products (Probiotics)

13/14 Respiratory and Special Pathogens (LRSP) Arciniega Development and refinement of potency and toxicity tests for bacterial vaccines Burns Bacterial toxin structure/function relationships Study of host response to immunization with anthrax and Staphylococcal aureus vaccines Keller Clostridial neurotoxin vaccine and antitoxin research Merkel Development of animal aerosol challenge models for pertussis, anthrax and disease caused by Staphylococcus aureus. Analysis of gene regulation in Bordetella pertussis Schmitt Characterization of iron transport systems of Corynebacterium diphtheriae Analysis of gene regulation in C. diphtheriae

14/14 LBP presenters Willie F. Vann, PhD John Cipollo, PhD Mustafa Akkoyunlu, MD, PhD Daron I. Freedberg, PhD Wei Wang, PhD Margaret C. Bash, MD